Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
, employing advanced statistical methods and cutting-edge artificial intelligence techniques to uncover novel insights into these complex interactions. As part of this position, you will have the opportunity
-
part of our team, you will leverage state-of-the-art single-cell, spatial and organoid technologies in a collaborative and interdisciplinary environment. Research focus We welcome candidates with a
-
journals. Experience with stereotaxic surgery and circuit-level manipulations is highly desirable. Communication skills the ability to work both independently and as part of a team. Why Join Us: Work in an
-
| Full-time/Part-time | Remote work possible DESY, with more than 2900 employees at its two locations in Hamburg and Zeuthen, is one of the world's leading research centres. Its research focuses
-
The Klco lab is looking for a post-doctoral fellow interested in using mouse and human models to understand pediatric AML and MDS. We are part of the Department of Pathology and the Center
-
supported by the lab's infrastructure, which includes a wet-lab component. Postdocs have considerable flexibility and freedom to develop their research programs. St. Jude provides a highly interactive and
-
dark oxygen production. Processes of this type were recently discovered in microbial cultures and could be important for microbial communities and element cycling in natural systems. However, the
-
scales. The project involves the modelling of energy infrastructures, the development of scenario-based simulations, and the generation of actionable indicators to support decision-making. You will be part
-
Postdoctoral researcher (m/f/d) – Medical Department for Hematology, Oncology, and Cell Therapy The Faculty of Medicine is an integral part of the Otto-von-Guericke-University Magdeburg and
-
. The postdoctoral position is part of the Carl Zeiss Foundation-funded “ImmuneMPS” consortium, which aims to develop microphysiological systems to advance understanding of cancer–immune interactions. The consortium